Management of severe community-acquired pneumonia of children in developing and developed countries

Thorax. 2011 Sep;66(9):815-22. doi: 10.1136/thx.2010.142604. Epub 2010 Oct 21.

Abstract

Childhood community-acquired pneumonia (CAP) is common, and recent data have shown that the number of children with severe CAP is increasing worldwide. Regardless of geographical area, severe cases are those at the highest risk of hospitalisation, prolonged hospitalisation and death, and therefore require prompt identification and the most effective treatment in order to reduce CAP-related morbidity and mortality. This review evaluates the available data concerning the diagnosis and treatment of severe and/or complicated cases of paediatric CAP in developed and developing countries. It also underlines the fact that any evidence-based recommendations require more research in various areas, including the aetiology of severe cases and the reasons for the complications, the better definition of first-choice antibiotic treatment and when surgery may be useful, and the role of chest physiotherapy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Child
  • Community-Acquired Infections* / diagnosis
  • Community-Acquired Infections* / epidemiology
  • Community-Acquired Infections* / therapy
  • Developing Countries*
  • Hospitalization*
  • Humans
  • Morbidity / trends
  • Pneumonia, Bacterial* / diagnosis
  • Pneumonia, Bacterial* / epidemiology
  • Pneumonia, Bacterial* / therapy
  • Severity of Illness Index
  • Survival Rate / trends
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents